Samarth Kulkarni sold $2.4M of CRSP stock

Samarth Kulkarni, Chief Executive Officer of CRISPR Therapeutics AG (CRSP), sold 47,837 shares of CRSP stock worth $2.4M, per an SEC Form 4 filed Oct 20, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 16, 2026, 4 days before it was made public.

CRSP has moved -13.5% since the trade date, from $49.25 to $42.62 (Nov 12, 2026 close).